知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

25 records (took 0.014 seconds)

    METHOD OF ASSEMBLING AND FILLING A DRUG DELIVERY DEVICE
    12.
    发明申请
    METHOD OF ASSEMBLING AND FILLING A DRUG DELIVERY DEVICE 审中-公开
    装配和填充药物递送装置的方法

    公开(公告)号：US20160199583A1

    公开(公告)日：2016-07-14

    申请号：US15047815

    申请日：2016-02-19

    Applicant: AMGEN INC.

    Inventor： Francisca Tan-Malecki ,  Ronald Forster ,  Scott M. Nunn ,  Son C. Tran ,  Sheldon Moberg ,  Mark D. Holt

    IPC: A61M5/31 ,  B65B55/10 ,  B65B55/08 ,  B65B3/00 ,  B65B7/28

    Abstract: An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product, including a granulocyte colony-stimulating factor (G-CSF). The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

    Abstract translation: 注射器可以包括具有带有内表面的壁和具有内表面的密封组件的容器，壁的内表面和密封组件限定了填充有药物产品的封闭的无菌容器，其包括粒细胞集落刺激因子 （G-CSF）。 注射器还可以包括流体输送系统，该流体输送系统包括清洁的，未被加热的刚性容器针，其具有仅在部分地通过密封组件处于储存状态的点，并且设置成通过密封组件的内表面输送到无菌容器中 州。 此外，注射可以包括适于将容器针从储存状态移动到输送状态的致动器。

    INJECTOR AND METHOD OF ASSEMBLY
    13.
    发明申请
    INJECTOR AND METHOD OF ASSEMBLY 审中-公开
    注射器和组装方法

    公开(公告)号：US20160199578A1

    公开(公告)日：2016-07-14

    申请号：US15040308

    申请日：2016-02-10

    Applicant: AMGEN INC.

    Inventor： Francisca Tan-Malecki ,  Ronald Forster ,  Scott M. Nunn ,  Mark D. Holt ,  Son C. Tran ,  Sheldon Moberg

    IPC: A61M5/24 ,  A61M5/172

    Abstract: An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product. The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

    Abstract translation: 注射器可以包括具有内表面的壁和具有内表面的密封组件的容器，壁的内表面和密封组件限定了充满药物的封闭的无菌容器。 注射器还可以包括流体输送系统，该流体输送系统包括清洁的，未被加热的刚性容器针，其具有仅在部分地通过密封组件处于储存状态的点，并且设置成通过密封组件的内表面输送到无菌容器中 州。 此外，注射可以包括适于将容器针从储存状态移动到输送状态的致动器。

    INJECTOR AND METHOD OF ASSEMBLY
    14.
    发明申请
    INJECTOR AND METHOD OF ASSEMBLY 审中-公开
    注射器和组装方法

    公开(公告)号：US20160166765A1

    公开(公告)日：2016-06-16

    申请号：US15047792

    申请日：2016-02-19

    Applicant: AMGEN INC.

    Inventor： Francisca Tan-Malecki ,  Ronald Forster ,  Scott M. Nunn ,  Mark D. Holt ,  Son C. Tran ,  Sheldon Moberg

    IPC: A61M5/162 ,  A61M5/148 ,  A61M5/158 ,  A61M5/145

    Abstract: An injector may include a container having a wall with an interior surface and a seal assembly with an interior surface, the interior surfaces of the wall and the seal assembly defining a closed sterile reservoir filled with a drug product, including a granulocyte colony-stimulating factor (G-CSF). The injector may also include a fluid delivery system comprising a clean, unsheathed, rigid container needle having a point disposed only partially through the seal assembly in a storage state, and disposed through the interior surface of the seal assembly into the sterile reservoir in a delivery state. Further, the injection may include an actuator that is adapted to move the container needle from the storage state to the delivery state.

    Abstract translation: 注射器可以包括具有带有内表面的壁和具有内表面的密封组件的容器，壁的内表面和密封组件限定了填充有药物产品的封闭的无菌容器，其包括粒细胞集落刺激因子 （G-CSF）。 注射器还可以包括流体输送系统，该流体输送系统包括清洁的，未被加热的刚性容器针，其具有仅在部分地通过密封组件处于储存状态的点，并且设置成通过密封组件的内表面输送到无菌容器中 州。 此外，注射可以包括适于将容器针从储存状态移动到输送状态的致动器。

    Drug delivery system with temperature-sensitive control
    18.
    发明授权
    Drug delivery system with temperature-sensitive control 有权

    公开(公告)号：US11383047B2

    公开(公告)日：2022-07-12

    申请号：US16589037

    申请日：2019-09-30

    Applicant: AMGEN INC.

    Inventor： Scott R. Gibson ,  Mark Ka Lai Lee ,  Donald Busby ,  Stephanie Toy ,  Suhas Krishna ,  Francisca Tan-Malecki ,  Ferry Tamtoro

    IPC: A61M5/44 ,  A61M5/315 ,  A61M5/20 ,  A61M5/142 ,  A61M5/162 ,  A61M5/172 ,  A61M5/31

    Abstract: A drug delivery system includes a reservoir and a drug delivery device coupled to the reservoir. The drug delivery device also may include at least one temperature-sensitive component and a lock having locked and unlocked states. The system further includes an output device, and a controller coupled to the lock and the output device. The controller may also include a temperature sensor, or may be coupled to the temperature sensor. The controller is programmed or configured to determine if the temperature of a drug in the reservoir or of the temperature-sensitive component exceeds an upper limit or is below a lower limit, and to activate the lock in either event. The controller is also programmed or configured to determine, directly or indirectly, if the temperature subsequently is between the upper and lower limits, and to unlock lock as a consequence.

    Drug delivery system with temperature-sensitive control
    20.
    发明授权
    Drug delivery system with temperature-sensitive control 有权

    公开(公告)号：US10758683B2

    公开(公告)日：2020-09-01

    申请号：US14913928

    申请日：2014-10-22

    Applicant: AMGEN INC.

    Inventor： Scott R. Gibson ,  Mark Ka Lai Lee ,  Donald Busby ,  Stephanie Toy ,  Suhas Krishna ,  Francisca Tan-Malecki ,  Ferry Tamtoro

    IPC: A61M5/44 ,  A61M5/162 ,  A61M5/315 ,  A61M5/20 ,  A61M5/142 ,  A61M5/172 ,  A61M5/31

    Abstract: A drug delivery system includes a reservoir and a drug delivery device coupled to the reservoir. The drug delivery device also may include at least one temperature-sensitive component and a lock having locked and unlocked states. The system further includes an output device, and a controller coupled to the lock and the output device. The controller may also include a temperature sensor, or may be coupled to the temperature sensor. The controller is programmed or configured to determine if the temperature of a drug in the reservoir or of the temperature-sensitive component exceeds an upper limit or is below a lower limit, and to activate the lock in either event. The controller is also programmed or configured to determine, directly or indirectly, if the temperature subsequently is between the upper and lower limits, and to unlock lock as a consequence.

Patent Agency Ranking